Hamostaseologie

Article	Citations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	42
Mitteilungen aus der Vorstandsarbeit	38
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	24
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	22
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	21
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	19
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	19
Mansoor’s self-report tool for cardiovascular risk assessment predicts adverse in-hospital events in patients with pulmonary embolism	18
	18
Participation of T helper cell-mediated negative regulation of coagulation in human arterial thrombosis	18
Current diagnostic and therapeutic standard of iliac vein compression syndrome (May-Thurner syndrome) in children, adolescents and young adults. A survey among national thrombosis experts	14
Immune tolerance achievement by low dose factor VIII in PUPs and MTPs under prophylaxis with emicizumab: two case reports	14
Recombinant ADAMTS13 treatment in a pregnant patient with hereditary thrombotic thrombocytopenic purpura	14
Preanalytical quenching of FVIII using FVIII-inhibitors improves the specificity of functional emicizumab testing	13
Diagnostic challenges of Thrombotic Thrombocytopenic Purpura: Results from a cohort of 3,100 individual patients in a time period of 21 months	13
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays	12
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses	12
Possible immune reaction to COVID-19 vaccination - a case report	12
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome	11
A novel assay to quantify extrinsic tenase complexes in body fluids	10
ITAM upregulation in platelets after major surgery	10
Komplementdysregulation als Biomarker für Post Covid	9
	9
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	8
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	8

Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	8
Sulodexid: Neue Hoffnung bei retinalen Gefäßerkrankungen	8
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	8
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	8
Development of Antidrug Inhibitory Antibodies against Polyethylene Glycol after Treatment with PEGylated Factor VIII Therapeutic	7
Insights in pain processing of affected versus non-affected structures	7
Subsegmental Pulmonary Embolism	7
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II	7
Impaired hemostatic capacity in patients with low von Willebrand factor	7
Platelets in Myocardial Ischemia/Reperfusion Injury	7
	7
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Follow-up evaluation of real-life-data documented by smart medication eDiary	7
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports	6
A Survey on anticoagulation in patient with ITP	6
Platelets are pre-activated during thrombocytopenia in a subset of early malaria infections	6
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism	6
Immune modulation by the endothelial protein C receptor (EPCR) in cancer progression	6
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis	5
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?	5
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	5
Management of Antithrombin Deficiency in Pregnancy	5
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)	5
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	5
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score	5
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)	5
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease	5
Reference Intervals in Coagulation Analysis	5
Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemost	4
Increased transfusion requirement in children compared to adults undergoing cardiac surgery	4
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	4
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice	4
GTH News	4
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey	4
Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank	4
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome	4
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	4
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	4
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	4
Influenza infections destabilize established immune tolerance in HemA mice	4
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)	4
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells	4
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome	4
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	4
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin	4
Recurrent Venous Thrombosis in a Hypofibrinogenemic Patient Despite a Heterozygous Deletion of the Fibrinogen Gene Cluster and Hemizygous FGB p.Pro265Leu Variant Mimicking a Homozygous Genotype	3
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors	3
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	3
Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia	3
Survey on the care reality of people with mild hemophilia A and B in Germany - the burden of mild hemophilia	3
Influence of coagulation proteases on cognitive function	3

Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	3
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing	3
EMIIL - Non-interventional study to investigate the effectiveness of Emicizumab under real-world conditions in pediatric, adolescent, adult and elderly patients with hemophilia A (PwHA) with and witho	3
Familial Protein S deficiency with severe venous thromboembolism (VTE)	3
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop	3
Elevated plasminogen activator inhibitor-1 is not associated with impaired plasmin formation and thrombotic risk after low-grade coagulation activation in vivo	3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	3
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	3
Venous Thrombosis and SARS-CoV-2	3
Evaluating the individual risk of venous thrombo-embolism in patients with liver cirrhosis: Usefulness of in vivo and ex vivo thrombin generation parameters	3
Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etr	3
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien	3
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets	3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification	3
	2
Treatment of Inherited Platelet Disorders: Current Status and Future Options	2
Endothelial protein C receptor signaling regulates myeloid-biased hematopoiesis under stress and in aging	2
Bleeding Risk in Patients with Cancer	2
Telomere length is associated with increased risk of cardiovascular events in hemodialysis patients	2
Digital joint discovery tool to support hemophilia patient education	2
Pharmazeutische Unternehmen außerhalb der USA unter Druck	2
Endogenous FVIII activity and procedure-related FVIII use and bleeding: post hoc analysis of GENEr8-1	2
Acquired von Willebrand Syndrome in Children	2
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	2
Non-clinical pharmacodynamic effects and immunogenicity assessment of prophylactic immune modulation prior to gene therapy dose administration in C57BL/6 mice	2
Inhibition of cold-induced apoptosis of platelet concentrates improves platelet functionality and half-life	2
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	2
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer	2
Communication in Healthcare: Global challenges in the 21st Century	2
GTH News	2
HEM-POWR study: Subgroup analysis evaluating the real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Germany	2
Venous Thromboembolism Issues in Women	1
Ontogeny of peripheral blood platelet GPIIb/IIIa activation and granule release in preterm and term neonates	1
Isolation of vWF-specific antibody fragments from phage-displayed scFv libraries	1
Comparison of closure time and whole blood impedance aggregometry to light transmission platelet aggregometry for the assessment of platelet response to aspirin and P2Y12 inhibitor therapies: a large-	1
Treatment of a patient with von Willebrand disease type 2B and severe thrombocytopenia due to mutation p.V1316M with thrombopoietin receptor agonist Avatrombopag	1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting	1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	1
Animal and Cellular Models in Thrombosis and Hemostasis	1
The Timed Up and Go Test in Patients with Haemophilia: Assessing Reliability, Validity, and Predictive Variables	1
Saliva and urine from persons with hemophilia A trigger coagulation bypassing factor VIII	1
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	1
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia®) Activity Using Reagent-/Platform-Specific Conversion Factors	1
Subsequent vaccinations in VITT patients other than SARS-CoV2 vaccination	1
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	1
Sequential combinations of rapid immunoassays for quick recognition of heparin-induced thrombocytopenia	1
The Use of Large Animal Models in Trauma and Bleeding Studies	1
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	1
Platelet Dysregulation in the Pathobiology of COVID-19	1
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	1
Interim 52-Week analysis of immunogenicity to the vector capsid and transgene-expressed human FVIII in GENEr8-1, a phase 3 clinical study of valoctocogene roxaparvovec, an AAV5-mediated gene therapy f	1
Second- and third-generation FVIII-specific CAR Treg responses to FVIII are functionally affected by the combination of FVIII-specific scFvs and intracellular costimulatory domains	1
Understanding the biomolecular corona formation at the nano-bio interface	1
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	1
Association Between Major Bleeding and In-Hospital Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes	1
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
GTH News	1
Correlation between coagulation factor residual activities and detection rate of diseasecausing variants in Rare Bleeding Disorders	1
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	1
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model	1
The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation	1
Haemostaseological pearls	1
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]	1
A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis	1
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry	1
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia	1
Periinterventional management of edoxaban in major procedures: results from the DRESDEN NOAC REGISTRY	1
Identification of key regulators of procoagulant COAT platelet generation by quantitative phosphoproteomic analysis and phosphoflow	1
Global seroprevalence of neutralizing antibodies against adeno-associated virus (AAV) serotypes of relevance to gene therapy	1
Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B	1
The effect of prophylactic corticosteroid treatment on adeno-associated virus-mediated gene therapy and potential mechanisms of action	1
Investigation of Differential Interaction between GGCX and VKD Clotting Factors by an In Silico Approach	1
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	1
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP	1

Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay	1
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	1
Treatment of Atypical Clots	1
	1
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability	1
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	1
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis	1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	1
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec	0
Randomized-controlled cross-over pilot study on the effectiveness of manual lymphatic drainage in patients with hemophilic arthropathy	0
Developing an assay to distinguish between HIT and VITT antibodies	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel	0
Women's Health Issues in Thrombosis and Haemostasis	0
At the forefront of the introduction of gene therapy in hemophilia A and B: Design and implementation of an innovative software platform ("smart medication Gene") for gene therapy	0
Gut microbiota promotes arterial thrombus formation in hyperlipidemic Ldlr-/- mouse model	0
In-vitro Evaluation of Anti-PEG Antibody Effects on the Activation of PEGylated Therapeutic FVIII and FIX Products	0
Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A	0
	0
Characterization of patient-derived anti-PF4 antibodies in chemiluminescence assays	0
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
Pitfalls in Coagulation Testing	0
Thrombotic Ghost as a Complication of Anticoagulation Therapy: The Challenge of Anticoagulating Intracardiac Thrombi in Patients with Factor VII Deficiency	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Venous thromboembolism therapy with edoxaban in daily - care patients: results from the DRESDEN NOAC REGISTRY	0
	0
Hemostasis modification in the presence of concizumab combined with donors' platelets, rFVIIa and/or tranexamic acid assessed by modified rotational thromboelastometry in patients with Glanzm	0
VITT-like anti-PF4 antibodies need to be considered in patients with thrombocytopenia and thrombosis	0
Disorders of Thrombosis and Hemostasis in Cancer	0
	0
	0
Molecular Genetics of Fletcher and Fitzgerald Traits	0
The phenotypic and genetic assessment of hereditary antithrombin deficiency in 215 patients from the Rhein-Ruhr area in Germany	0
Intrinsic Activated Thrombin Generation for Efficacy and Monitoring of Factor VIII Replacements and Mimetics	0
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1	0
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec (CSL222) vs. extended half-life Factor IX therapies for severe or moderately severe hemophilia B	0
Conformational opening of ADAMTS13 does not necessarily indicate preactivation of its metalloprotease domain	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study	0
Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma	0
Laboratory Monitoring in Patients Receiving Emicizumab	0
Aktueller Stand zur Reform der Gebührenordnung für Ärzte (GOÄ)	0
Utility of ACMG classification to support interpretation of molecular genetic test results in patients with FVII deficiency	0
Von Willebrand-disease_ a patient with a variant of uncertain significance: phenotype like type 1, genotype like type 3	0
Controlling Patient Multiple Electrode Aggregometry Results with Blood Samples of Blood Donors Improves Clinical Interpretation	0
Evaluation of platelet parameters in pediatric oncology patients undergoing myelotoxic chemotherapy.	0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0
G-BA entscheidet Festgruppe für (plasmatischen) Blutgerinnungsfaktor VIII	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
Paving the way to assay automation: Improving and simplifying VWF activity determination of VWF concentrates	0
A hierarchical network of Src, Syk, Btk and PKC controls GPVI-dependent human platelet activation	0
GPVI-mediated platelet activation aggravates inflammation and progressive aortic wall remodelling in abdominal aortic aneurysm formation	0
Etranacogene dezaparvovec hemophilia B gene therapy phase 2b trial final results: stable and durable FIX level expression over 5 years [ENCORE]	0
Double CRISPR/Cas9-knockout of ER chaperones, ERGIC transporters and GABARAPs reveal additive and dominant effect on FVIII secretion	0
Grundlagen zur Anwendung von Andexanet	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
Tackling the implementation hurdle: User-centric validation of a machine-learning decision support tool for the screening of mild bleeding disorders	0
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI Activity	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
TFPI deletion in myeloid cells exacerbates atherosclerotic plaque development	0
Natural history of isolated distal deep vein thrombosis without anticoagulation. Prospective cohort under ultrasound surveillance	0
Platelet hyperactivation and neutrophil extracellular traps promote thrombo-inflammation and glomerular endothelial dysfunction in diabetic kidney disease	0
Platelet responsiveness in the post-acute phase of pulmonary embolism	0
Aggregates of non-muscle myosin IIA in the erythrocytes associate with GATA1-related thrombocytopenia	0
Erratum to: Congenital Fibrinogen Deficiencies: Not So Rare	0
Relation of FVIII activity levels with global assays of hemostasis in persons with hemophilia A	0
Detection of joint bleeding symptoms in Haemophilia with the Noraxon system – pilot study	0
Oral Anticoagulation and Mortality in Cases with Intracranial Bleeding: Analysis of Nationwide Prescription and Hospitalization Data	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
In Contrast to Full-Length Factor VIII, the Calnexin (ER Chaperone) and LMAN1 (ERGIC transporter) Knockouts Have Minimal Effect on the Secretion of B-Domain-Deleted Factor VIII: Implication for Gene T	0
The impact of enhanced platelet turnover on platelet reactivity in healthy humans	0
A novel solid phase assay for the detection of fibrinolytic activities	0
Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors	0
Marcumar-Intoxication: The Perils of Near-Homonyms	0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors	0
Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia: a prospective validation study	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
The effect of DNA methylation on inhibitor development in haemophilia A patients treated with FVIII concentrates	0
	0
Analysis of the platelet activation profile in a novel experimental mouse model of AAA formation and progression	0
Blutverlust bei Frauen im gebärfähigen Alter aufgrund oraler Antikoagulanzien gegen venöse Thromboembolien	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Epithelial thrombin-PAR1 signaling and Nippostrongylus brasiliensis infection drive small intestinal villus vascularization	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
Applicability of and adherence to anticoagulation-related standard-operating-procedures in standard surgical procedures – a single center quality control experience	0
Joint health and physical activity in people with haemophilia A without factor VIII inhibitors before switching to emicizumab prophylaxis: Beyond ABR study interim analysis	0
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia	0
Hypercoagulability combined with routine laboratory parameters accurately predicts liver cirrhosis decompensation	0